Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, Jiumei Xinhe, resulting in an estimated net loss of RMB740.55. The proceeds from this transaction will be utilized as general working capital for the company. This move reflects the company’s strategic adjustments amidst challenging financial conditions.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.